Initial vancomycin versus metronidazole for the treatment of first-episode non-severe Clostridioides difficile infection

OBJECTIVE: Clostridioides difficile infection (CDI) is the leading cause of infectious nosocomial diarrhea. Although initial fidaxomicin or vancomycin treatment is recommended by most major guidelines to treat severe CDI, there exists varied recommendations for first-episode non-severe CDI. Given th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kevin, Beckett, Patricia, Abouanaser, Salaheddin, Smieja, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495603/
https://www.ncbi.nlm.nih.gov/pubmed/36168487
http://dx.doi.org/10.1017/ash.2021.194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495603/
https://www.ncbi.nlm.nih.gov/pubmed/36168487
http://dx.doi.org/10.1017/ash.2021.194

Ejemplares similares